Beyond the Clouds: Anesthesia for Cannabis Enthusiasts

On This Episode:

The intersection of cannabis use, vaping and anesthesia is a topic that’s sparking conversations in operating rooms and beyond. With marijuana legalization spreading across the globe and vaping gaining popularity, it’s crucial for healthcare providers and patients alike to understand how these factors can impact the surgical experience. In this episode, we’ll explore this topic and share the considerations CRNAs need to make when dealing with cannabis users.

From the pharmacokinetics and pharmacodynamics of cannabis to the clinical considerations for patients who vape marijuana, we’ll explore it all. We’ll discuss recent clinical findings, guidelines for safe anesthetic management, and practical tips for navigating surgery in a cannabis world.

Whether you’re a seasoned healthcare professional or a curious listener, join us as we uncover the essential insights needed to ensure safe and effective anesthesia in the age of marijuana.

 

Here’s some of what we discuss in this episode:

  • The science behind how cannabis interacts with our bodies.
  • The physiological effects of cannabis use.
  • A breakdown of vaping and what it means for those heading into surgery.
  • How it impacts the postoperative period.

 

References

Abrams DI, Vizoso HP, Shade SB, et al. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther 2007;82(5):572–8.

Ahrens E, Wachtendorf LJ, Chiarella LS, et al. Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study. EClinicalMedicine 2023;57:101831.

Alexander JC, Joshi GP. A review of the anesthetic implications of marijuana use. Proc – Bayl Univ Med Cent 2019;32(3):364–71.

Anderson GD, Chan LN. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clin Pharmacokinet 2016;55(11): 1353–68.

Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol 2012;2(6):241–54.

Bergeria CL, Spindle TR, Cone EJ, et al. Pharmacokinetic Profile of D9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products. J Anal Toxicol 2022;46(6):583–91.

Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Opposite effects of delta-9- tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacol 2010;35(3):764–74.

Blessing EM, SteenkampMM,Manzanares J, et al. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurother J Am Soc Exp Neurother 2015;12(4):825–36.

Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil 2017;8:9–37.

Brunet B, Doucet C, Venisse N, et al. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues. Forensic Sci Int 2006;161(2–3):169–74.

Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addict Abingdon Engl 2015;110(11):1699–704.

Cabral GA, Rogers TJ, Lichtman AH. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. J Neuroimmune Pharmacol 2015;10(2):193–203.

Cullen KA, Gentzke AS, Sawdey MD, et al. e-Cigarette Use Among Youth in the United States, 2019. JAMA 2019;322(21):2095–103.

D’Souza DC, Perry E, MacDougall L, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol 2004;29(8):1558–72.

El-Mahdy MA, Mahgoup EM, Ewees MG, et al. Long-term electronic cigarette exposure induces cardiovascular dysfunction similar to tobacco cigarettes: role of nicotine and exposure duration. Am J Physiol Heart Circ Physiol 2021; 320(5):H2112–29.

Farokhnia M, McDiarmid GR, Newmeyer MN, et al. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry 2020;10(1):71.

Flisberg P, Paech MJ, Shah T, et al. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol 2009;26(3):192–5.

Fordjour E, Manful CF, Sey AA, et al. Cannabis: a multifaceted plant with endless potentials. Front Pharmacol 2023;14. Available at: https://www.frontiersin.org/ articles/10.3389/fphar.2023.1200269. Accessed March 30, 2024.

Fusar-Poli P, Crippa JA, Bhattacharyya S, et al. Distinct Effects of D9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing. Arch Gen Psychiatry 2009;66(1):95–105.

Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend 2012;123(1–3):141–7.

Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019;380(7):629–37.

Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2010;35(1):42–7.

He T, Oks M, Esposito M, et al. “Tree-in-Bloom”: Severe Acute Lung Injury Induced by Vaping Cannabis Oil. Ann Am Thorac Soc 2017;14(3):468–70.

Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54(2):161–202.

Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4(8): 1770–804.

Johal H, Devji T, Chang Y, et al. Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis. Clin Med Insights Arthritis Musculoskelet Disord 2020;13. https://doi.org/10.1177/1179544120906461. 1179544120906461

Johansson E, Agurell S, Hollister LE, et al. Prolonged apparent half-life of delta 1- tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol 1988;40(5):374–5.

Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42(S1):58S–63S.

Kallurkar, Anusha, et al. “Marijuana Use, Vaping, and Preoperative Anesthetic and Surgical Considerations in Clinical Practice.” Anesthesiology Clinics, vol. 42, no. 1, 2024, pp. 53–63, https://doi.org/10.1016/j.anclin.2023.09.001.

Karst M, Salim K, Burstein S, et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA 2003; 290(13):1757–62.

Kaplan AG. Cannabis and Lung Health: Does the Bad Outweigh the Good? Pulm Ther 2021;7(2):395–408.

Koo CM, Kim SH, Lee JS, et al. Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea. J Korean Med Sci 2020;35(50):e427.

Ladha KS, McLaren-Blades A, Goel A, et al. Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process. Br J Anaesth 2021;126(1):304–18.

Laudanski K, Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J Clin Med 2022;11(3):558.

Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report. N Engl J Med 2020;382(10):903–16.

Leweke FM, Piomelli D, Pahlisch F, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2012;2(3):e94.

Levin DN, Dulberg Z, Chan AW, et al. A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery. Can J Anaesth J Can Anesth 2017;64(4):385–95.

Liu CW, Bhatia A, Buzon-Tan A, et al. Weeding Out the Problem: The Impact of Preoperative Cannabinoid Use on Pain in the Perioperative Period. Anesth Analg 2019;129(3):874–81.

Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346(6284):561–4.

Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365(6441):61–5.

Manzanares J, Corchero J, Romero J, et al. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999;20(7): 287–94.

Morean ME, Kong G, Camenga DR, et al. High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis. Pediatrics 2015;136(4):611–6.

Ohlsson A, Lindgren JE, Wahlen A, et al. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 1980;28(3):409–16.

Perioperative Considerations of Cannabis Use on Anesthesia Administration. Anesthesia Patient Safety Foundation. Available at: https://www.apsf.org/article/ perioperative-considerations-of-cannabis-use-on-anesthesia-administration/. Accessed March 30, 2024.

Perlman AI, McLeod HM, Ventresca EC, et al. Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities. Mayo Clin Proc 2021;96(10):2671–81.

Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 2008;153(2):199–215.

Prashad S, Filbey FM. Cognitive motor deficits in cannabis users. Curr Opin Behav Sci 2017;13:1–7.

Reagan-Steiner S, Gary J, Matkovic E, et al. Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series. Lancet Respir Med 2020;8(12):1219–32.

Riggs PK, Vaida F, Rossi SS, et al. A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Res 2012;1431:46–52.

Russo EB, Burnett A, Hall B, et al. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 2005;30(8):1037–43.

Schwope DM, Karschner EL, Gorelick DA, et al. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 2011; 57(10):1406–14.

Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med 2023;48(3):97–117.

Shah S, Patel S, Paulraj S, et al. Association of Marijuana Use and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Data Analysis of 133,706 US Adults. Am J Med 2021;134(5):614–20.e1.

Sholler DJ, Spindle TR, Cone EJ, et al. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), D9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration. J Anal Toxicol 2022;46(5):494–503.

Sorensen CJ, DeSanto K, Borgelt L, et al. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review. J Med Toxicol 2017;13(1):71–87.

Spindle TR, Cone EJ, Schlienz NJ, et al. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. JAMA Netw Open 2018;1(7):e184841.

State Medical Cannabis Laws. Available at: https://www.ncsl.org/health/statemedical-cannabis-laws. Accessed March 30, 2024.

Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addict Abingdon Engl 2000;95(11):1669–77.

Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Lond Engl 2018;391(10125):1085–96.

Vigano` D, Rubino T, Parolaro D. Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav 2005;81(2):360–8.

Vu_ckovi_c S, Srebro D, Vujovi_c KS, et al. Cannabinoids and Pain: New Insights From Old Molecules. Front Pharmacol 2018;9:1259.

 

Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

 


SHARE THIS EPISODE

Facebook
Twitter
LinkedIn

SUBSCRIBE

EXPLORE MORE

CRNA Careers

Balancing a Career in Music with Being a CRNA

In this episode, Sharon and guest host Tracy Castleman, DNP, CRNA, APN-A, FAANA sit down David Giardinelli-O’Connor, PhD, DNAP, CRNA, who has successfully balanced a demanding career in anesthesia with his lifelong passion for music.

LISTEN NOW »

SUBSCRIBE

NEW EPISODES EVERY WEEK!

Apple PodcastsSpotifyTuneIniHeartRadio

HAVE A QUESTION OR WANT TO BE GUEST?

RECENT REVIEWS

J. Cross CRNA
Read More
This podcast is very well put together. I love the hosts Sharon & Jeremy, they do a fantastic job at presenting topics as well as getting great speakers on the show! This is my morning commute podcast everyday! Thank you for all that you do!
Bill.Nye
Read More
I enjoy listening every morning. Great content and always a pleasure to learn something new.
biggestbaseballfanever
Read More
I started listening to this podcast religiously early on in my CRNA journey, a year before applying to CRNA school. The content in this podcast was one of my most helpful resources for getting into my first choice school, Wake Forest! It has also been a huge motivator for getting involved with the AANA now and throughout my career. I highly recommend this podcast to every prospective CRNA I meet.
Trvlgrl1
Read More
I appreciate hearing the latest and greatest in the world of Nurse Anesthesiology while also getting Class B credits. Just listen on your commute for a win/win experience. I love the perspectives from Jeremy and Sharon who both ask varied and insightful questions!
doubledownmoney
Read More
If you’re a CRNA or any medical professional, I highly recommend giving this podcast a listen. Hosts have a great rapport.
Previous
Next

READ MORE REVIEWS OR LEAVE YOUR OWN!